Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Profile of a factor Xa inhibitor in development at Yamanouchi

May 6, 1998

FDA advisory committee recommends approval of Aggrastat

May 4, 1998

XR-300: in vitro and in vivo characterization of new antiplatelet/antithrombotic agent

May 4, 1998

Fraxiparine now listed on Canadian health plan formularies

April 30, 1998

Aspirin versus warfarin for the prevention of stroke in patients with atrial fibrillation

April 29, 1998

Phase I data reported for Vasoflux at ACC meeting in Rio

April 28, 1998

Orbofiban: a fibrinogen antagonist for the treatment of acute coronary syndromes

April 28, 1998

t-PA treatment may be beneficial to stroke patients and health care systems

April 28, 1998

New hirudin option now available in U.K.

April 27, 1998

Markers of thrombin and their relation to clinical outcome after myocardial infarction

April 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...